Helix BiopharmaHBP 
$0.975.60%24h
5.60%24h
Global rank17039
Market cap$187.35M
Change 7d0.00%
YTD Performance528.57%
SP500 benchmarkOutperform
P/E-32.32
P/S0
Revenue$0
Earnings-$4.62M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Helix Biopharma (HBP)
As of November 2024, Helix Biopharma has a market cap of $187.35M. This makes Helix Biopharma the world's 17039th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Helix Biopharma from 1996 to 2024
-
Value:-
Market cap history of Helix Biopharma from 1996 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $24.13M | -19.05% |
| 2023 | $29.81M | -4.55% |
| 2022 | $31.22M | -26.67% |
| 2021 | $42.58M | -40.00% |
| 2020 | $70.96M | -62.69% |
| 2019 | $190.18M | 152.83% |
| 2018 | $75.22M | -43.62% |
| 2017 | $133.41M | -38.96% |
| 2016 | $218.57M | -23.00% |
| 2015 | $283.86M | 11.11% |
| 2014 | $255.47M | 25.00% |
| 2013 | $204.38M | 22.03% |
| 2012 | $167.48M | -37.89% |
| 2011 | $269.66M | -26.07% |
| 2010 | $364.76M | -19.94% |
| 2009 | $455.59M | 68.95% |
| 2008 | $269.66M | -13.64% |
| 2007 | $312.24M | 18.92% |
| 2006 | $262.57M | -55.10% |
| 2005 | $584.75M | 17.71% |
| 2004 | $496.75M | -20.45% |
| 2003 | $624.49M | 47.16% |
| 2002 | $424.37M | 22.54% |
| 2001 | $346.31M | -61.88% |
| 2000 | $908.34M | 218.41% |
| 1999 | $285.28M | 402.50% |
| 1998 | $56.77M | 0.00% |
| 1997 | $56.77M | -75.76% |
| 1996 | $234.18M | - |
HBP Market Cap Today is $187.35M 5.60% - 22 Nov 2024
View largest stocks by market cap 
